|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$81,530.05 |
2.42% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$79,630.32 |
2.37% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$79,177.93 |
2.35% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$78,316.55 |
2.33% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$76,937.04 |
2.29% |
| Steris Plc |
STE |
G8473T100 |
298 |
$76,708.18 |
2.28% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$75,357.21 |
2.24% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$74,966.16 |
2.23% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$73,977.36 |
2.20% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$73,496.09 |
2.18% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$73,351.74 |
2.18% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$73,300.62 |
2.18% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$73,230.08 |
2.17% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$73,143.15 |
2.17% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$72,804.04 |
2.16% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$72,605.50 |
2.16% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$72,471.00 |
2.15% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$71,921.24 |
2.14% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$71,406.72 |
2.12% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$70,230.95 |
2.09% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$70,003.00 |
2.08% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$69,464.70 |
2.06% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$68,745.82 |
2.04% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,730.06 |
2.04% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$68,475.59 |
2.03% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$67,671.52 |
2.01% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$67,223.82 |
2.00% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$66,595.23 |
1.98% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$66,618.63 |
1.98% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$66,122.30 |
1.96% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$66,071.67 |
1.96% |
| Waters Corporation |
WAT |
941848103 |
147 |
$66,117.66 |
1.96% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$65,699.07 |
1.95% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$65,010.03 |
1.93% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$64,582.50 |
1.92% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$64,415.91 |
1.91% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$63,810.89 |
1.90% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$63,822.00 |
1.90% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$63,617.82 |
1.89% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$62,683.25 |
1.86% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$62,350.40 |
1.85% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$61,931.17 |
1.84% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$61,332.85 |
1.82% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$60,347.30 |
1.79% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$59,981.43 |
1.78% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$57,933.73 |
1.72% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$57,371.40 |
1.70% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$56,405.30 |
1.68% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,539.47 |
1.32% |
| US Dollar |
$USD |
|
23,183 |
$23,183.34 |
0.69% |
| Japanese Yen |
$JPY |
|
237,600 |
$1,490.87 |
0.04% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|